// App-Quantinova.ai

THU0250 : URINE AND SERUM S100 PROTEINS ASSOCIATE WITH LUPUS NEPHRITIS AND RESPONSE TO TREATMENT

Researchers

Presenter

  • J. Davies

Principal Investigators

  • A. Midgley

  • S. Donohue

  • I. N. Bruce

  • M. Beresford

  • C. Hedrich

Medical Centers

  • University of Liverpool, Institute of Translational Medicine, Department of Women’s and Children’s Health, Liverpool, United Kingdom

  • University of Manchester, Arthritis Research UK Epidemiology Unit, Faculty of Biology Medicine and Health, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Autoimmune (AI)

Disease

  • Lupus nephritis

  • Renal disease

  • Nephritis

  • Lupus

Biomarkers

  • S100 calcium-binding protein A12

  • S100 calcium-binding protein B

Drug/Treatment

  • Rituximab

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Genzyme and Sanofi

Result

  • N/A